Amyloidosis trials in Norway

In Norway 8 Also abroad 184

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Oslo
Age
18 years to 90 years
People
1,200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
Phase 3Enrolling by invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Oslo
Age
18 years and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
Phase 3Taking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Aalesund, Loerenskog
Age
18 years to 85 years
People
1,750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
Phase 4Taking people
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
Where
Oslo
Age
18 years to 90 years
People
50 worldwide
Run by
Bayer
See details and how to joinNCT07298044 · EU 2025-521831-35-00
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Age
18 years and over
People
2,000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
Phase 3Not yet taking people in Norway
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Lorenskog, Oslo, Trondheim
People
1,180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
No phaseTaking people
ATTR Cardiac Amyloidosis in a Selected Population
Where
Ålesund
Age
50 years and over
People
180
Run by
Helse Møre og Romsdal HF
See details and how to joinNCT06458374
No phaseTaking people
The Norwegian Immunotherapy in Multiple Myeloma Study
Where
Ålesund, Arendal, Bærum, Bergen, Bodø, Drammen, Førde, Gjøvik, Haugesund, Kristiansand, Kristiansund, Levanger, Molde, Nordbyhagen, Oslo, Skien, Stavanger, Tønsberg, Tromsø, Trondheim, Volda
Age
18 years and over
People
400
Run by
St. Olavs Hospital
See details and how to joinNCT06855121